Literature DB >> 8947932

Morphine-induced increase in D-1 receptor regulated signal transduction in rat striatal neurons and its facilitation by glucocorticoid receptor activation: possible role in behavioral sensitization.

A N Schoffelmeer1, P Voorn, A J Jonker, G Wardeh, P Nestby, L J Vanderschuren, T J De Vries, A H Mulder, G H Tjon.   

Abstract

One month (but not 1-3 days) after intermittent morphine administration, the hyperresponsiveness of rats toward the locomotor effects of morphine and amphetamine was associated with an increase in dopamine (DA) D-1 receptor-stimulated adenylyl cyclase activity and enhanced steady state levels of preprodynorphin gene expression in slices of the caudate/putamen and nucleus accumbens. Such an enduring increase in postsynaptic D-1 receptor efficacy also occurred in cultured gamma-aminobutyric acid (GABA) neurons of the striatum obtained from rats prenatally treated with morphine. Interestingly, in vitro glucocorticoid receptor activation in these cultured striatal neurons by corticosterone potentiated this neuroadaptive effect of prior in vivo morphine exposure. Since activation of glucocorticoid receptors by corticosterone did not affect D-1 receptor functioning in cultured neurons of saline-pretreated rats, prior intermittent exposure to morphine (somehow) appears to induce a long-lasting state of corticosterone hyperresponsiveness in striatal neurons. Therefore, DA-sensitive striatal GABA neurons may represent common neuronal substrates acted upon by morphine and corticosterone. We hypothesize that the delayed occurrence of these long-lasting morphine-induced neuroadaptive effects in GABA/dynorphin neurons of the striatum is involved in the enduring nature of behavioral sensitization to drugs of abuse and cross-sensitization to stressors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947932     DOI: 10.1007/bf02532383

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  38 in total

1.  Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism.

Authors:  C Rivier; W Vale
Journal:  Brain Res       Date:  1987-10-06       Impact factor: 3.252

2.  Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments.

Authors:  B T Hope; H E Nye; M B Kelz; D W Self; M J Iadarola; Y Nakabeppu; R S Duman; E J Nestler
Journal:  Neuron       Date:  1994-11       Impact factor: 17.173

3.  Stress-induced sensitization and glucocorticoids. I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion.

Authors:  V Deroche; M Marinelli; S Maccari; M Le Moal; H Simon; P V Piazza
Journal:  J Neurosci       Date:  1995-11       Impact factor: 6.167

4.  Ontogeny of behavioral sensitization in the rat: effects of direct and indirect dopamine agonists.

Authors:  S A McDougall; M A Duke; C A Bolanos; C A Crawford
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

5.  Amphetamine regulates gene expression in rat striatum via transcription factor CREB.

Authors:  C Konradi; R L Cole; S Heckers; S E Hyman
Journal:  J Neurosci       Date:  1994-09       Impact factor: 6.167

6.  Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya.

Authors:  P W Kalivas; P Duffy
Journal:  J Neurosci       Date:  1993-01       Impact factor: 6.167

7.  Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals.

Authors:  P W Kalivas; P Duffy
Journal:  J Neurosci       Date:  1993-01       Impact factor: 6.167

8.  Persistence of the ability of amphetamine preexposure to facilitate acquisition of cocaine self-administration.

Authors:  A Valadez; S Schenk
Journal:  Pharmacol Biochem Behav       Date:  1994-01       Impact factor: 3.533

9.  Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulation.

Authors:  G H Tjon; T J De Vries; E Ronken; F Hogenboom; G Wardeh; A H Mulder; A N Schoffelmeer
Journal:  Eur J Pharmacol       Date:  1994-02-03       Impact factor: 4.432

10.  Glucocorticoid receptor activation potentiates the morphine-induced adaptive increase in dopamine D-1 receptor efficacy in gamma-aminobutyric acid neurons of rat striatum/nucleus accumbens.

Authors:  A N Schoffelmeer; T J De Vries; L J Vanderschuren; G H Tjon; P Nestby; G Wardeh; A H Mulder
Journal:  J Pharmacol Exp Ther       Date:  1995-09       Impact factor: 4.030

View more
  5 in total

Review 1.  Neural mechanisms of reproduction in females as a predisposing factor for drug addiction.

Authors:  Valerie L Hedges; Nancy A Staffend; Robert L Meisel
Journal:  Front Neuroendocrinol       Date:  2010-02-19       Impact factor: 8.606

2.  Long-term upregulation of protein kinase A and adenylate cyclase levels in human smokers.

Authors:  Bruce T Hope; Deepti Nagarkar; Sherry Leonard; Roy A Wise
Journal:  J Neurosci       Date:  2007-02-21       Impact factor: 6.167

3.  Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior.

Authors:  D W Self; L M Genova; B T Hope; W J Barnhart; J J Spencer; E J Nestler
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

4.  Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice.

Authors:  Julie Salzmann; Cynthia Marie-Claire; Stephanie Le Guen; Bernard P Roques; Florence Noble
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

Review 5.  A Trigger for Opioid Misuse: Chronic Pain and Stress Dysregulate the Mesolimbic Pathway and Kappa Opioid System.

Authors:  Nicolas Massaly; Jose A Morón; Ream Al-Hasani
Journal:  Front Neurosci       Date:  2016-11-07       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.